BioNTech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioNTech using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $-0.14 | $0.75 | -118.7 % |
| Q2 | 2025-08-04 | $-1.82 | $-1.31 | -38.9 % |
| Q1 | 2025-05-05 | $-1.82 | $-2.35 | 22.6 % |
| Q4 | 2025-03-10 | $1.15 | $0.37 | 210.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $1.78B | $1.19B | 49.2 % |
| Q2 | 2025-08-04 | $295.70M | $643.87M | -54.1 % |
| Q1 | 2025-05-05 | $192.23M | $161.67M | 18.9 % |
| Q4 | 2025-03-10 | $1.27B | $1.15B | 10.4 % |
BioNTech (BNTX) is scheduled to report earnings on March 9, 2026. The last reported earnings were for reported on November 3, 2025 for Q3.
The Actual EPS was $-0.14, which missed the estimate of $0.75.
The Actual Revenue was $1.8B, which beat the estimate of $1.2B.
Browse earnings estimates, EPS, and revenue on all stocks.